Issue 3/2004
Content (20 Articles)
The active metabolite of leflunomide, A77 1726, increases the production of IL-1 receptor antagonist in human synovial fibroblasts and articular chondrocytes
Gaby Palmer, Danielle Burger, Françoise Mezin, David Magne, Cem Gabay, Jean-Michel Dayer, Pierre-André Guerne
Increased AP-1 and NF-κB activation and recruitment with the combination of the proinflammatory cytokines IL-1β, tumor necrosis factor alpha and IL-17 in rheumatoid synoviocytes
Corinne Granet, Wova Maslinski, Pierre Miossec
Cortisol and hypothalamic–pituitary–gonadal axis hormones in follicular-phase women with fibromyalgia and chronic fatigue syndrome and effect of depressive symptoms on these hormones
Ali Gur, Remzi Cevik, Kemal Nas, Leyla Colpan, Serdar Sarac
Association of a specific haplotype across the genes MMP1 and MMP3 with radiographic joint destruction in rheumatoid arthritis
Sylvia Dörr, Nadine Lechtenböhmer, Rolf Rau, Gertraud Herborn, Ulf Wagner, Bertram Müller-Myhsok, Ingo Hansmann, Gernot Keyszer
Treatment with recombinant interferon-β reduces inflammation and slows cartilage destruction in the collagen-induced arthritis model of rheumatoid arthritis
Judith van Holten, Kris Reedquist, Pascale Sattonet-Roche, Tom JM Smeets, Christine Plater-Zyberk, Margriet J Vervoordeldonk, Paul P Tak
Relationship between radiographic grading of osteoarthritis and the biochemical markers for arthritis in knee osteoarthritis
Masaaki Takahashi, Kenichi Naito, Masashi Abe, Tomokazu Sawada, Akira Nagano
Enhanced osteoclast development in collagen-induced arthritis in interferon-γ receptor knock-out mice as related to increased splenic CD11b+myelopoiesis
Bert De Klerck, Isabelle Carpentier, Rik J Lories, Yvette Habraken, Jacques Piette, Geert Carmeliet, Rudi Beyaert, Alfons Billiau, Patrick Matthys
Induction of IL-10-producing CD4+CD25+T cells in animal model of collagen-induced arthritis by oral administration of type II collagen
So-Youn Min, Sue-Yun Hwang, Kyung-Su Park, Jae-sun Lee, Kang-Eun Lee, Kyung-Wun Kim, Young-Ok Jung, Hyunk-Jae Koh, Ju-Ho Do, Haerim Kim, Ho-Youn Kim
Equipoise, design bias, and randomized controlled trials: the elusive ethics of new drug development
James F Fries, Eswar Krishnan
Chemokine blockade: a new era in the treatment of rheumatoid arthritis?
Jasper J Haringman, Paul P Tak
Autoantibody profile in rheumatoid arthritis during long-term infliximab treatment
Francesca Bobbio-Pallavicini, Claudia Alpini, Roberto Caporali, Stefano Avalle, Serena Bugatti, Carlomaurizio Montecucco
Delayed resolution of acute inflammation during zymosan-induced arthritis in leptin-deficient mice
Eiva Bernotiene, Gaby Palmer, Dominique Talabot-Ayer, Ildiko Szalay-Quinodoz, Michel L Aubert, Cem Gabay
CD14 mediates the innate immune responses to arthritopathogenic peptidoglycan–polysaccharide complexes of Gram-positive bacterial cell walls
Xiangli Li, Blair U Bradford, Frederick Dalldorf, Sanna M Goyert, Stephen A Stimpson, Ronald G Thurman, Sergei S Makarov
Psychological stress and fibromyalgia: a review of the evidence suggesting a neuroendocrine link
Anindya Gupta, Alan J Silman
Effect of phospholipase A2inhibitory peptide on inflammatory arthritis in a TNF transgenic mouse model: a time-course ultrastructural study
Maung-Maung Thwin, Eleni Douni, Vassilis Aidinis, George Kollias, Kyoko Kodama, Kazuki Sato, Ramapatna L Satish, Ratha Mahendran, Ponnampalam Gopalakrishnakone
Citrullinated proteins: sparks that may ignite the fire in rheumatoid arthritis
Erik R Vossenaar, Walther J van Venrooij
A surplus of positive trials: weighing biases and reconsidering equipoise
David T Felson, Leonard Glantz
Gene expression signatures for autoimmune disease in peripheral blood mononuclear cells
Nancy J Olsen, Jason H Moore, Thomas M Aune